Will the Sun Pharmaceutical Industries share price run continue?
In this article we will quickly re-cap the broker forecasts for Sun Pharmaceutical Industries (NSI:SUNPHARMA).
The Sun Pharmaceutical Industries share price has risen by 12.2% over the past month and it’s currently trading at 571.35. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.
According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Sun Pharmaceutical Industries currently has:
- 14 Buy recommendations
- 1 Hold recommendations
- 1 Sell recommendations
This suggests that analysts are generally positive about the outlook.
Questioning broker positivity
At its current price of 571.35, shares in Sun Pharmaceutical Industries are trading at a discount of -2.52% to its 52 week high price. The 1-year performance of the shares has been 34.4%.
While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Sun Pharmaceutical Industries it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Sun Pharmaceutical Industries that you can find out about here.
About us
Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.